[Therapeutics of infection by Helicobacter pylori in 2008].
Eradication therapy for Helicobacter pylori is recommended in a number of clinical conditions as developed in Maastricht Consensus (I, II, III). In this state of art we discuss the results of current eradication therapies, the new approaches to the management of infection (new antibiotics and eradication schemes) and antimicrobial resistance.
Corti
Rodolfo
R
Unidad de Esófago y Estómago, Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo, Facultad de Medicina, Universidad de Buenos Aires, Argentina. rodolfocorti@hotmail.com
Doweck
Judith
J
Schenone
Liliana
L
Améndola
Rafael
R
Giordano Romano
Adriana
A
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans
D000900:Anti-Bacterial Agents